Discovery of novel potent triple IKZF1/2/3 degraders for the treatment of hematological cancers
Ontology highlight
ABSTRACT: Through subsequent investigations into structure-activity relationships (SAR) and protein degradation mechanisms, we developed a novel and highly effective candidate, MGD-22, demonstrates potent inhibition of hematological cancer growth across a broad range of models and overcame acquired resistance to IMiDs.
ORGANISM(S): Homo Sapiens
SUBMITTER:
Weijie Qin
PROVIDER: PXD059572 | iProX | Wed Jan 08 00:00:00 GMT 2025
REPOSITORIES: iProX
ACCESS DATA